SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
SEC Accession No. 0001493152-24-001610
Filing Date
2024-01-05
Accepted
2024-01-05 17:27:26
Documents
44

Document Format Files

Seq Description Document Type Size
1 formsc13da.htm SC 13D/A 341581
2 ex99-3.htm EX-99.3 40930
3 ex99-3_001.jpg GRAPHIC 302825
4 ex99-3_002.jpg GRAPHIC 365767
5 ex99-3_003.jpg GRAPHIC 360436
6 ex99-3_004.jpg GRAPHIC 338614
7 ex99-3_005.jpg GRAPHIC 334363
8 ex99-3_006.jpg GRAPHIC 347472
9 ex99-3_007.jpg GRAPHIC 328982
10 ex99-3_008.jpg GRAPHIC 345479
11 ex99-3_009.jpg GRAPHIC 341922
12 ex99-3_010.jpg GRAPHIC 337526
13 ex99-3_011.jpg GRAPHIC 350833
14 ex99-3_012.jpg GRAPHIC 391664
15 ex99-3_013.jpg GRAPHIC 361603
16 ex99-3_014.jpg GRAPHIC 372641
17 ex99-3_015.jpg GRAPHIC 360244
18 ex99-3_016.jpg GRAPHIC 344619
19 ex99-3_017.jpg GRAPHIC 388982
20 ex99-3_018.jpg GRAPHIC 359315
21 ex99-3_019.jpg GRAPHIC 357392
22 ex99-3_020.jpg GRAPHIC 372953
23 ex99-3_021.jpg GRAPHIC 349548
24 ex99-3_022.jpg GRAPHIC 310272
25 ex99-3_023.jpg GRAPHIC 371240
26 ex99-3_024.jpg GRAPHIC 370378
27 ex99-3_025.jpg GRAPHIC 334656
28 ex99-3_026.jpg GRAPHIC 362127
29 ex99-3_027.jpg GRAPHIC 381605
30 ex99-3_028.jpg GRAPHIC 358143
31 ex99-3_029.jpg GRAPHIC 344608
32 ex99-3_030.jpg GRAPHIC 366860
33 ex99-3_031.jpg GRAPHIC 352037
34 ex99-3_032.jpg GRAPHIC 336892
35 ex99-3_033.jpg GRAPHIC 365268
36 ex99-3_034.jpg GRAPHIC 344667
37 ex99-3_035.jpg GRAPHIC 304966
38 ex99-3_036.jpg GRAPHIC 312093
39 ex99-3_037.jpg GRAPHIC 343114
40 ex99-3_038.jpg GRAPHIC 319015
41 ex99-3_039.jpg GRAPHIC 350685
42 ex99-3_040.jpg GRAPHIC 292300
43 ex99-3_041.jpg GRAPHIC 295068
44 ex99-3_042.jpg GRAPHIC 52562
  Complete submission text file 0001493152-24-001610.txt   20058074
Mailing Address 3060 PEGASUS PARK DRIVE BUILDING 6 DALLAS TX 75247
Business Address 3060 PEGASUS PARK DRIVE BUILDING 6 DALLAS TX 75247 (310) 618-6994
Forte Biosciences, Inc. (Subject) CIK: 0001419041 (see all company filings)

IRS No.: 261243872 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13D/A | Act: 34 | File No.: 005-89959 | Film No.: 24517596
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address CAMAC CAPITAL, LLC 350 PARK AVENUE, 13TH FLOOR NEW YORK NY 10022
Business Address CAMAC CAPITAL, LLC 350 PARK AVENUE, 13TH FLOOR NEW YORK NY 10022 914-629-8496
Camac Fund, LP (Filed by) CIK: 0001516478 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13D/A